Reference ID: 3306791 - Food and Drug …
of chickenpox or measles can occur in susceptible patients. (5.6) HIGHLIGHTS OF PRESCRIBING INFORMATION BREO ELLIPTA inhaler safely and effectively.
Download Reference ID: 3306791 - Food and Drug …
Information
Domain:
Source:
Link to this page:
Documents from same domain
Effexor (venlafaxine hydrochloride) Tablets …
www.accessdata.fda.govEffexor ® (venlafaxine hydrochloride) Tablets Rx only . Suicidality and Antidepressant Drugs Antidepressants increased the risk compared …
Reference ID: 3101735 - Food and Drug …
www.accessdata.fda.govDocetaxel Injection in combination with doxorubicin and cyclophosphamide is indicated for the adjuvant treatment of patients with operable node-positive breast cancer.
Cytotec® - Food and Drug Administration
www.accessdata.fda.govcytotec® (misoprostol) warnings cytotec (misoprostol) administration to women who are pregnant can cause abortion, premature birth, or birth defects.
HIGHLIGHTS OF PRESCRIBING INFORMATION …
www.accessdata.fda.govweakness, diplopia, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence and breathing difficulties. These symptoms . FULL …
Namenda XR (memantine hydrochloride) capsules …
www.accessdata.fda.govThe most commonly observed adverse reactions seen in patients administered NAMENDA XR in the controlled clinical trial, defined as those occurring at a frequency of at least 5% in the
FOR INTRAVENOUS USE ONLY - Food and Drug …
www.accessdata.fda.govNDA 50-706/S-022 Page 3 MERREM® I.V. (meropenem for injection) FOR INTRAVENOUS USE ONLY To reduce the development of drug-resistant bacteria and maintain the effectiveness of
NOT FOR USE IN NEONATES CONTAINS BENZYL …
www.accessdata.fda.govDepo-Medrol® methylprednisolone acetate injectable suspension, USP NOT FOR USE IN NEONATES CONTAINS BENZYL ALCOHOL . Not For Intravenous Use . DESCRIPTION
HIGHLIGHTS OF PRESCRIBING INFORMATION …
www.accessdata.fda.govDacogen is indicated for treatment of patients with myelodysplastic syndromes (MDS) including previously treated and untreated, de novo and …
Venofer - Food and Drug Administration
www.accessdata.fda.govNDA 21-135/S-017 Page 3 Venofer ® (iron sucrose injection, USP) Rx Only DESCRIPTION Venofer® (iron sucrose injection, USP) is a brown, sterile, aqueous, complex of …
Diphenhydramine Hydrochloride Injection
www.accessdata.fda.govHOW SUPPLIED Diphenhydramine Hydrochloride Injection, USP is a clear and colorless solution available as: 50 mg/mL in a 1 mL prefilled single-use syringe.
Related documents
Polypharmacy: Guidance for Prescribing - AWMSG
www.awmsg.orgPolypharmacy: Guidance for Prescribing Supplementary Guidance – BNF Sections to Target . July 2014
WARNINGS AND PRECAUTIONS----------------- - PI …
www.azpicentral.comHIGHLIGHTS OF PRESCRIBING INFORMATION. These highlights do not include all the information needed to use BEVESPI AEROSPHERE safely and effectively.
HIGHLIGHTS OF PRESCRIBING INFORMATION - PI …
www.azpicentral.comHIGHLIGHTS OF PRESCRIBING INFORMATION. These highlights do not include all the information needed to use SYMBICORT safely and effectively. See full prescribing information for SYMBICORT.
GUIDELINES FOR THE USE OF BENZODIAZEPINES …
www.benzos.une.edu1 GUIDELINES FOR THE USE OF BENZODIAZEPINES IN OFFICE PRACTICE IN THE STATE OF MAINE Introduction: This is an evidence based guideline for the use of benzodiazepines and related drugs in
Prescribing Information - docs.boehringer …
docs.boehringer-ingelheim.comFULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE 1.1 Maintenance Treatment of Chronic Obstructive Pulmonary Disease SPIRIVA RESPIMAT (tiotropium bromide) is indicated for the long- term, once-daily, maintenance treatment of bronchospasm associated with chronic obstructive
HIGHLIGHTS OF PRESCRIBING INFORMATION ...
docs.boehringer-ingelheim.comHIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use STIOLTO RESPIMAT safely and effectively.
History of known hypersensitivity to indacaterol ...
www.utibron.comfull prescribing information: contents* warning: asthma-related death 1 indications and usage 2 dosage and administration 3 dosage forms and strengths